Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death.
We investigated the effect of uncoupling astrocytic gap junctions on neuronal vulnerability to oxidative injury in embryonic rat hippocampal cell cultures. Mixed cultures (neurons growing on an astrocyte monolayer) treated with 18-alpha-glycyrrhetinic acid (GA), an uncoupler of gap junctions, showed markedly enhanced generation of intracellular peroxides (2,7-dichlorofluorescein fluorescence), impairment of mitochondrial function [(dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction], and cell death (lactate dehydrogenase release) following exposure to oxidative insults (FeSO4 and 4-hydroxynonenal). GA alone had little or no effect on basal levels of peroxides, mitochondrial function, or neuronal survival. Intercellular dye transfer analyses revealed extensive astrocyte-astrocyte coupling but no astrocyte-neuron or neuron-neuron coupling in the mixed cultures. Studies of pure astrocyte cultures and microscope analyses of neurons in mixed cultures showed that the increased oxidative stress and cell death in GA-treated cultures occurred only in neurons and not in astrocytes. Antioxidants (propyl gallate and glutathione) blocked the death of neurons exposed to FeSO4/GA. Elevations of neuronal intracellular calcium levels ([Ca2+]i) induced by FeSO4 were enhanced in neurons in mixed cultures exposed to GA. Removal of extracellular Ca2+ and the L-type Ca2+ channel blocker nimodipine prevented impairment of mitochondrial function and cell death induced by FeSO4 and GA, whereas glutamate receptor antagonists were ineffective. Finally, GA exacerbated kainate- and FeSO4-induced injury to pyramidal neurons in organotypic hippocampal slice cultures. The data suggest that interastrocytic gap junctional communication decreases neuronal vulnerability to oxidative injury by a mechanism involving stabilization of cellular calcium homeostasis and dissipation of oxidative stress.
Blanc
E M
EM
Sanders-Brown Research Center on Aging and Department of Anatomy and Neurobiology, University of Kentucky, Lexington 40536-0230, USA.
Bruce-Keller
A J
AJ
Mattson
M P
MP
D000287:Administration, Topical; D000447:Aldehydes / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000931:Antidotes / Q000494:pharmacology; D001253:Astrocytes / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D002450:Cell Communication / Q000502:physiology*; D016923:Cell Death / Q000502:physiology; D002478:Cells, Cultured; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D005290:Ferric Compounds / Q000494:pharmacology; D017629:Gap Junctions / Q000502:physiology*; D005978:Glutathione / Q000494:pharmacology; D006034:Glycyrrhetinic Acid / Q000494:pharmacology; D006624:Hippocampus / Q000166:cytology; D006706:Homeostasis / Q000502:physiology; D006861:Hydrogen Peroxide; D015227:Lipid Peroxidation / Q000502:physiology; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000737:chemistry / Q000166:cytology* / Q000378:metabolism; D009498:Neurotoxins / Q000494:pharmacology; D009924:Organ Culture Techniques; D018384:Oxidative Stress / Q000502:physiology; D011435:Propyl Gallate / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017470:Receptors, Glutamate / Q000502:physiology
D000447:Aldehydes; D000893:Anti-Inflammatory Agents; D000931:Antidotes; D015853:Cysteine Proteinase Inhibitors; D005290:Ferric Compounds; D009498:Neurotoxins; D017470:Receptors, Glutamate; C024823:ferric sulfate; D011435:Propyl Gallate; D006861:Hydrogen Peroxide; D005978:Glutathione; C027576:4-hydroxy-2-nonenal; D006034:Glycyrrhetinic Acid; D002118:Calcium